176 related articles for article (PubMed ID: 38259448)
1. Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3.
Schadeck J; Oberg HH; Peipp M; Hedemann N; Schamel WW; Bauerschlag D; Wesch D
Front Immunol; 2023; 14():1286097. PubMed ID: 38259448
[TBL] [Abstract][Full Text] [Related]
2. Bispecific antibodies enhance tumor-infiltrating T cell cytotoxicity against autologous HER-2-expressing high-grade ovarian tumors.
Oberg HH; Janitschke L; Sulaj V; Weimer J; Gonnermann D; Hedemann N; Arnold N; Kabelitz D; Peipp M; Bauerschlag D; Wesch D
J Leukoc Biol; 2020 Jun; 107(6):1081-1095. PubMed ID: 31833593
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3 Released by Pancreatic Ductal Adenocarcinoma Suppresses γδ T Cell Proliferation but Not Their Cytotoxicity.
Gonnermann D; Oberg HH; Lettau M; Peipp M; Bauerschlag D; Sebens S; Kabelitz D; Wesch D
Front Immunol; 2020; 11():1328. PubMed ID: 32695112
[TBL] [Abstract][Full Text] [Related]
4. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
[TBL] [Abstract][Full Text] [Related]
5. Analysis of tumor-infiltrating gamma delta T cells in rectal cancer.
Rong L; Li K; Li R; Liu HM; Sun R; Liu XY
World J Gastroenterol; 2016 Apr; 22(13):3573-80. PubMed ID: 27053849
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 vaccination influences subtypes of γδ-T cells during pregnancy.
Wang L; Li J; Jiang S; Li Y; Guo R; Chen Y; Chen Y; Yu H; Qiao Q; Zhan M; Yin Z; Xiang Z; Xu C; Xu Y
Front Immunol; 2022; 13():900556. PubMed ID: 36311780
[TBL] [Abstract][Full Text] [Related]
7. Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian Cancer.
Weimer P; Wellbrock J; Sturmheit T; Oliveira-Ferrer L; Ding Y; Menzel S; Witt M; Hell L; Schmalfeldt B; Bokemeyer C; Fiedler W; Brauneck F
Cells; 2022 Mar; 11(6):. PubMed ID: 35326415
[TBL] [Abstract][Full Text] [Related]
8. Long-term use of interferon-β in multiple sclerosis increases Vδ1
Maimaitijiang G; Watanabe M; Shinoda K; Isobe N; Nakamura Y; Masaki K; Matsushita T; Yoshikai Y; Kira JI
J Neuroinflammation; 2019 Sep; 16(1):179. PubMed ID: 31519178
[TBL] [Abstract][Full Text] [Related]
9. Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments.
Nguyen S; Chevalier MF; Benmerzoug S; Cesson V; Schneider AK; Rodrigues-Dias SC; Dartiguenave F; Lucca I; Jichlinski P; Roth B; Nardelli-Haefliger D; Derré L
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002184
[No Abstract] [Full Text] [Related]
10. Characteristics of Vδ1(+) and Vδ2(+) γδ T cell subsets in acute liver allograft rejection.
Yu X; Liu Z; Wang Y; Wang H; Zhang M; Sun Y; Su H; Jin L; Wang F; Shi M
Transpl Immunol; 2013 Dec; 29(1-4):118-22. PubMed ID: 24029467
[TBL] [Abstract][Full Text] [Related]
11. Blocking of EphA2 on Endometrial Tumor Cells Reduces Susceptibility to Vδ1 Gamma-Delta T-Cell-Mediated Killing.
Hudecek R; Kohlova B; Siskova I; Piskacek M; Knight A
Front Immunol; 2021; 12():752646. PubMed ID: 34691070
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and functional heterogeneity of peripheral γδ T cells in pulmonary TB and HIV patients in Addis Ababa, Ethiopia.
Negash M; Tsegaye A; Wassie L; Howe R
BMC Infect Dis; 2018 Sep; 18(1):464. PubMed ID: 30219039
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics of γδ T cell subsets induced from peripheral blood mononuclear cells of HIV/AIDS patients in vitro].
Chen WW; Wu XL; Nie WM; Xie YX; Wang L; Zhao M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):285-7. PubMed ID: 22394638
[TBL] [Abstract][Full Text] [Related]
14. Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies.
Deniger DC; Maiti SN; Mi T; Switzer KC; Ramachandran V; Hurton LV; Ang S; Olivares S; Rabinovich BA; Huls MH; Lee DA; Bast RC; Champlin RE; Cooper LJ
Clin Cancer Res; 2014 Nov; 20(22):5708-19. PubMed ID: 24833662
[TBL] [Abstract][Full Text] [Related]
15. Inversion of the Vδ1 to Vδ2 γδ T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion.
Paquin-Proulx D; Barsotti NS; Santos BAN; Marinho AKBB; Kokron CM; Carvalho KI; Barros MT; Kalil J; Nixon DF; Kallas EG
Medicine (Baltimore); 2016 Jul; 95(30):e4304. PubMed ID: 27472706
[TBL] [Abstract][Full Text] [Related]
16. Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells.
Siegers GM; Dhamko H; Wang XH; Mathieson AM; Kosaka Y; Felizardo TC; Medin JA; Tohda S; Schueler J; Fisch P; Keating A
Cytotherapy; 2011 Jul; 13(6):753-64. PubMed ID: 21314241
[TBL] [Abstract][Full Text] [Related]
17. Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.
Maeurer MJ; Martin D; Walter W; Liu K; Zitvogel L; Halusczcak K; Rabinowich H; Duquesnoy R; Storkus W; Lotze MT
J Exp Med; 1996 Apr; 183(4):1681-96. PubMed ID: 8666926
[TBL] [Abstract][Full Text] [Related]
18. Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab.
Wistuba-Hamprecht K; Martens A; Haehnel K; Geukes Foppen M; Yuan J; Postow MA; Wong P; Romano E; Khammari A; Dreno B; Capone M; Ascierto PA; Demuth I; Steinhagen-Thiessen E; Larbi A; Schilling B; Schadendorf D; Wolchok JD; Blank CU; Pawelec G; Garbe C; Weide B
Eur J Cancer; 2016 Sep; 64():116-26. PubMed ID: 27400322
[TBL] [Abstract][Full Text] [Related]
19. γδ T cell frequencies are altered in HIV positive pregnant South African women and are associated with preterm birth.
Akoto C; Chan CYS; Ravi K; Zhang W; Vatish M; Norris SA; Hemelaar J
PLoS One; 2020; 15(6):e0235162. PubMed ID: 32584913
[TBL] [Abstract][Full Text] [Related]
20. Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma.
Brauneck F; Weimer P; Schulze Zur Wiesch J; Weisel K; Leypoldt L; Vohwinkel G; Fritzsche B; Bokemeyer C; Wellbrock J; Fiedler W
Front Med (Lausanne); 2021; 8():763773. PubMed ID: 34820398
[No Abstract] [Full Text] [Related]
[Next] [New Search]